Pular para o conteúdo
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Todos os campos
Título
Autor
Assunto
Número de Chamada
ISBN/ISSN
Tag
Buscar
Avançada
Tumour expression of the DNA r...
Citar
Enviar por SMS
Enviar por e-mail
Imprimir
Exportar registro
Exportar para RefWorks
Exportar para EndNoteWeb
Exportar para EndNote
Link permanente
Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
Detalhes bibliográficos
Principais autores:
Gillies, R
,
Delaney, D
,
Warren, B
,
Sharma, R
,
Middleton, MR
Formato:
Conference item
Publicado em:
2011
Itens
Descrição
Registros relacionados
Registro fonte
Registros relacionados
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
por: Gillies, R, et al.
Publicado em: (2012)
Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
por: Gillies, R, et al.
Publicado em: (2012)
XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
por: Hatch, S, et al.
Publicado em: (2014)
Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
por: Graf, Nora, et al.
Publicado em: (2012)
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
por: MacGregor, T, et al.
Publicado em: (2018)